Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Myeloid 1Classical hematology 1

Conditions

Burkitt Lymphoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Biphenotypic, Acute 3Lymphoma, Mantle-Cell 2Leukemia, Myeloid, Accelerated Phase 2Down Syndrome 2Blast Crisis 2Renal Pelvis and Ureter Urothelial Carcinoma 1Osteosarcoma 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Carcinoma 1Blastic Plasmacytoid Dendritic Cell Neoplasm 1Anemia, Refractory, with Excess of Blasts 1

Interventions

fludarabine phosphate 3Whole-Body Irradiation 3Methotrexate 3Cyclophosphamide 3ponatinib 2merphos 2Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Melphalan 2Busulfan 2venetoclax 1blinatumomab 1Thiotepa 1Sirolimus 1Rituximab 1N,N-dicyclohexyl-isoborneol-10-sulfonamide 1Injections 1Etoposide 1Decitabine 1Cytarabine 1Cyclosporine 1Cord Blood Stem Cell Transplantation 1Clofarabine 1CT-P10 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, Myeloid, Accelerated Phase × merphos × 30 days × Clear all
NCT02220985 2026-06-01

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

Fred Hutchinson Cancer Center

Phase 2 Completed
84 enrolled 22 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03263572 2026-05-20

Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia

M.D. Anderson Cancer Center

Phase 2 Recruiting
90 enrolled
LymphoidOther hematologic neoplasm

Blast Crisis, Leukemia, Myeloid, Accelerated Phase, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡